<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23519">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02076113</url>
  </required_header>
  <id_info>
    <org_study_id>LCID: 2013-085</org_study_id>
    <secondary_id>CE-1304-6173</secondary_id>
    <nct_id>NCT02076113</nct_id>
  </id_info>
  <brief_title>Cervical Spondylotic Myelopathy Surgical Trial</brief_title>
  <official_title>Cervical Spondylotic Myelopathy Surgical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lahey Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient Centered Outcome Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lahey Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal)
      for patients with multi-level cervical spondylotic myelopathy (CSM). There are no
      established guidelines for the management of patients with CSM, which represents the most
      common cause of spinal cord injury and dysfunction in the US and in the world.

      This study aims to test the hypothesis that ventral surgery is associated with superior
      Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to
      dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord
      dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA).  A
      secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion,
      and laminoplasty surgery are different.  A third hypothesis is that cervical sagittal
      balance post-operatively is a significant predictor of SF-36 PCS outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients' images will be transmitted electronically (without identifying information) to a
      group of 15 CSM surgeon investigators for their expert opinion. They will provide their
      opinion on surgical strategy.  Equipoise for randomization will be established using this
      spinal experts network polling mechanism.

      If randomized, the patient will be randomized to one of the two treatment approaches -
      either Ventral (front) (treatment A) or Dorsal (back) (treatment B) approach.  If randomized
      to treatment A (front surgery), the patient will receive  decompression/fusion from the
      front of the neck. If randomized to treatment B (dorsal/back surgery), then the patient and
      their surgeon will select which posterior procedure they will receive (either dorsal
      decompression/fusion or dorsal laminoplasty).

      Treatment A:   Decompression/fusion from the front of the neck.

      Treatment B:   Dorsal/posterior neck surgery (one of the two surgical procedures listed
      below):

      Dorsal decompression/fusion or dorsal laminoplasty (no fusion)

      Functional outcomes will be determined using well-known quantitative scales (SF-36, Oswestry
      Neck Disability Index (NDI), mJOA, and EuroQol-5D).  These instruments will be administered
      pre-op, 3 months, 6 months, and at 1 year. Additionally, functional outcomes instruments
      (SF-36, Oswestry Neck Disability Index, and EuroQol-5D) will be collected annually at years
      2,3,4 and 5.

      Pre-op imaging will include a cervical MRI and cervical CT as well as cervical
      flexion/extension films and standing cervical-thoracic-lumbar-sacral x-ray . A cervical MRI
      will be performed at 3 months. At 1 year (randomized patients only) will undergo cervical
      flexion/ extension xrays and standing cervical-thoracic-lumbar-sacral x-ray . A cervical CT
      will be performed only if the Oswestry NDI score is &gt; 30.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Measurement of change in Short Form 36 (SF 36) physical component score (PCS) from baseline to 1 year</measure>
    <time_frame>Pre-operatively and 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Standardized measure of patient's functional health and well being as reported by the patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>modified Japanese Orthopedic Association Score mJOA</measure>
    <time_frame>Pre-operatively, 3 and 6 months and 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Short instrument for the functional assessment of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Neck Disability Index (NDI)</measure>
    <time_frame>Pre-operatively, 3 and 6 months and 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Standard instrument for measuring self-rated disability secondary to neck pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol-5 D</measure>
    <time_frame>Pre-operatively, 3 and 6 months and 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Standardized measure of health related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with 30 day complications</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Complications are considered Hospital Readmission, Re-operation or Death within 30 days of initial surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health resource utilization</measure>
    <time_frame>Pre-operatively, 1, 3 and 6 months and 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>patient diary capturing out of pocket health expenses related to cervical surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work Status</measure>
    <time_frame>pre-operative, 1, 3 and 6 months and 1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sagittal Balance Measurements</measure>
    <time_frame>Pre-op and 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>standing cervical-thoracic-lumbar-sacral xrays</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Cervical Spondylosis With Myelopathy</condition>
  <arm_group>
    <arm_group_label>Ventral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ventral Decompression with Fusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dorsal Decompression with Fusion or Dorsal Laminoplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ventral (Front) decompression with Fusion</intervention_name>
    <description>Ventral decompression and fusion will be performed using a multi-level discectomy (including partial or single level corpectomy) with fusion and plating. Allograft will be used at each disc space and all compressive osteophytes will be removed using the operating microscope. Fixation will be performed with rigid, semi-constrained, or dynamic titanium plates to optimize fusion and minimize complications.</description>
    <arm_group_label>Ventral</arm_group_label>
    <other_name>Anterior Cervical Discectomy and Fusion (ACDF)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dorsal (Back) Decompression with Fusion</intervention_name>
    <description>Dorsal decompression and fusion will be performed using midline cervical laminectomy with the application of lateral mass screws and rods for rigid fixation. All surgeons will use local bone and allograft as needed to perform a lateral mass fusion, which typically will include one level rostral to the levels decompressed.</description>
    <arm_group_label>Dorsal</arm_group_label>
    <other_name>Posterior decompression and fusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dorsal (back) Laminoplasty</intervention_name>
    <description>Laminoplasty will be performed using an open-door approach with the application of plates and screws at each treated level. Ceramic or allograft laminar spacers (surgeon's choice) can be used with plates and screws to expand the canal diameter.</description>
    <arm_group_label>Dorsal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CSM (≥2 levels of spinal cord compression from C3 to C7)

          -  Present with ≥2 of the following symptoms/signs: clumsy hands, gait disturbance,
             hyperreflexia, up going toes, bladder dysfunction.

        Exclusion Criteria:

          -  C2-C7 kyphosis&gt;5º (measured in standing neutral cervical spine radiograph),

          -  Segmental kyphotic deformity (defined by ≥3 osteophytes extending dorsal to a C2-C7
             dorsal-caudal line measured on cervical spine CT),

          -  Structurally significant ossification of posterior longitudinal ligament (OPLL -
             measured on cervical spine CT),

          -  Previous cervical spine surgery

          -  Significant active health-related co-morbidity (Anesthesia Class IV or higher).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoher Ghogawala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lahey Clinic, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susan R Christopher, RN</last_name>
    <phone>781-744-7904</phone>
    <email>susan.r.christopher@lahey.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean V Coumans, MD</last_name>
      <phone>617-726-3511</phone>
      <email>jcoumans@partners.org</email>
    </contact>
    <investigator>
      <last_name>Jean V Coumans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan R Christopher, RN</last_name>
      <phone>781-744-7904</phone>
      <email>susan.r.christopher@lahey.org</email>
    </contact>
    <contact_backup>
      <last_name>Jill N Curran, MS</last_name>
      <email>jill.n.curran@lahey.org</email>
    </contact_backup>
    <investigator>
      <last_name>Subu N Magge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert G. Whitmore, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine- St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Colleen Peters</last_name>
      <phone>314-747-2994</phone>
      <email>petersc@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Riew, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers-New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lorelei Pratt, RN</last_name>
      <phone>973-972-4702</phone>
      <email>lpratt@njms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Robert F Heary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10029-6574</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexa Dessy</last_name>
      <phone>646-258-2423</phone>
      <email>alexa.dessy@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Tanvir Choudhri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Zeleny</last_name>
      <phone>216-445-1861</phone>
      <email>zelenym@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Edward C Benzel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MetroHealth</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Nichols</last_name>
      <phone>216-957-6488</phone>
      <email>jnichols@metrohealth.org</email>
    </contact>
    <investigator>
      <last_name>Michael P Steinmetz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rothman Spine Institute- thomas jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Fu</last_name>
      <phone>267-339-3527</phone>
      <email>hong.fu@rothmaninstitute.com</email>
    </contact>
    <investigator>
      <last_name>Todd J Albert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James S Harrop, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan Hilibrand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Kepler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeff Rihn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alex Vaccaro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universityof Utah Health Sciences</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holly Hill, RN</last_name>
      <phone>801-581-6908</phone>
      <email>holly.hill@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sara McEvoy, PA</last_name>
      <phone>801-581-6908</phone>
      <email>sara.mcevoy@hsc.utah.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Erica F Bisson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Wollenweber</last_name>
      <phone>414-805-5403</phone>
      <email>lwollenw@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Marjorie C Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shekar N Kurpad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network-University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuriy Petrenko, MD</last_name>
      <phone>416-603-5285</phone>
      <email>yuriy.petrenko@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Michael G Fehlings, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohammed Shamji, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.pcori.org</url>
    <description>Patient Centered Outcomes Research Institute</description>
  </link>
  <link>
    <url>http://www.csm-study.org</url>
    <description>Study website for the Cervical Spondylotic Myelopathy Surgical Study</description>
  </link>
  <reference>
    <citation>Ghogawala Z, Martin B, Benzel EC, Dziura J, Magge SN, Abbed KM, Bisson EF, Shahid J, Coumans JV, Choudhri TF, Steinmetz MP, Krishnaney AA, King JT Jr, Butler WE, Barker FG 2nd, Heary RF. Comparative effectiveness of ventral vs dorsal surgery for cervical spondylotic myelopathy. Neurosurgery. 2011 Mar;68(3):622-30; discussion 630-1. doi: 10.1227/NEU.0b013e31820777cf.</citation>
    <PMID>21164373</PMID>
  </reference>
  <reference>
    <citation>Ghogawala Z, Coumans JV, Benzel EC, Stabile LM, Barker FG 2nd. Ventral versus dorsal decompression for cervical spondylotic myelopathy: surgeons' assessment of eligibility for randomization in a proposed randomized controlled trial: results of a survey of the Cervical Spine Research Society. Spine. 2007 Feb 15;32(4):429-36.</citation>
    <PMID>17304133</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 5, 2014</lastchanged_date>
  <firstreceived_date>February 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical spondylotic myelopathy</keyword>
  <keyword>degenerative cervical spondylosis</keyword>
  <keyword>spinal fusion</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bone Marrow Diseases</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Spondylosis</mesh_term>
    <mesh_term>Spinal Osteophytosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
